Preparation, characterization, and efficacy of thermosensitive liposomes containing paclitaxel

References

• Abu Lila AS, Kizuki S, Doi Y, et al. (2009). Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J Control Release 137:8–14.
   PubMed Web of Science ®Google Scholar
• Asai T, Miyazawa S, Maeda N, et al. (2008). Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC. Cancer Sci 99:1029–33.
   PubMed Web of Science ®Google Scholar
• Coradini K, Lima FO, Oliveira CM, et al. (2014). Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects. Eur J Pharm Biopharm 88:178–85.
   PubMed Web of Science ®Google Scholar
• De Smet M, Langereis S, van den Bosch S, Grüll H. (2010). Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Release 143:120–7.
   PubMed Web of Science ®Google Scholar
• Friedland D, Gorman G, Treat J. (1993). Hypersensitivity reactions from taxol and etoposide. J Natl Cancer Inst 85:2036–45.
   PubMed Web of Science ®Google Scholar
• Gaber MH, Wu NZ, Hong K, et al. (1996). Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys 36:1177–87.
   PubMed Web of Science ®Google Scholar
• Hauck ML, Coffin DO, Dodge RK, et al. (1997). A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumor interstitial fluid pressure. Int J Hyperthermia 13:307–16.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. (1997). Can mild hyperthermia improve tumour oxygenation? Int J Hyperthermia 13:141–7.
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, et al. (2010). Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–70.
   PubMed Web of Science ®Google Scholar
• Karino T, Koga S, Maeta M. (1988). Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. Jpn J Surg 18:276–83.
   PubMedGoogle Scholar
• Kim JH, Kim YS, Park K, et al. (2008). Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 127:41–9.
   PubMed Web of Science ®Google Scholar
• Kneidl B, Peller M, Winter G, et al. (2014). Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomedicine 9:4387–98.
   PubMed Web of Science ®Google Scholar
• Koning GA, Eggermont AM, Lindner LH, ten Hagen TL. (2010). Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 27:1750–4.
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, et al. (2000). Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 60:6950–7.
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. (2001). Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 61:3027–32.
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. (2000). Hyperthermia enables tumor specific nanoparticle delivery: effect of particle size. Cancer Res 60:4440–5.
   PubMed Web of Science ®Google Scholar
• Kong G, Dewhirst MW. (1999). Hyperthermia and liposomes. Int J Hyperthermia 15:345–70.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Paolino D, Celia C, et al. (2010). Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release 147:127–35.
   PubMed Web of Science ®Google Scholar
• May JP, Ernsting MJ, Undzys E, Li SD. (2013). Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors. Mol Pharm 10:4499–508.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Kondo M, Kawahara K, et al. (2007). Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis. Pharm Res 24:946–54.
   PubMed Web of Science ®Google Scholar
• Needham D, Anyarambhatla G, Kong G, Dewhirst MW. (2000). A new temperature sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 60:1197–201.
   PubMed Web of Science ®Google Scholar
• Ono A, Takeuchi K, Sukenari A, et al. (2002). Reconsideration of drug release from temperature-sensitive liposomes. Biol Pharm Bull 25:97–101.
   PubMed Web of Science ®Google Scholar
• Shikanov A, Shikanov S, Vaisman B, et al. (2008). Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant. Int J Pharm 358:114–20.
   PubMed Web of Science ®Google Scholar
• Simona M, Julien N, Patrick C. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003.
   PubMed Web of Science ®Google Scholar
• Simone L, Jasmin H, Rebecca S, et al. (2014). Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes. Pharm Res 31:2276–86.
   PubMed Web of Science ®Google Scholar
• Singla AK, Garg A, Aggarwal D. (2002). Paclitaxel and its formulations. Int J Pharm 235:179–92.
   PubMed Web of Science ®Google Scholar
• Szebeni J, Muggia FM, Alving CR. (1998). Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst 90:300–6.
   PubMed Web of Science ®Google Scholar
• van Zuylen L, Karlsson MO, Verweij J, et al. (2001). Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles. Cancer Chemother Pharmacol 47:309–18.
   PubMed Web of Science ®Google Scholar
• Wang XL, Song YZ, Su YQ, et al. (2015). Are PEGylated liposomes better than conventional liposomes? A special case for vincristine. Drug Deliv. [Epub ahead of print]. doi:10.3109/10717544.2015.1027015.
   Google Scholar
• Xie X, Yang Y, Yang Y, et al. (2015). A photo-responsive peptide- and asparagines-glycine-arginine (NGR) peptide-mediated liposomal delivery system. Drug Deliv. [Epub ahead of print]. doi:10.3109/10717544.2015.1008707.
   Google Scholar
• Yang YF, Yang Y, Xie XY, et al. (2014). PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy. Biomaterials 34:368–81.
   Google Scholar
• Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. (1978). Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202:1290–3.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang ZY, Gong W, et al. (2011). Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate. Int J Pharm 414:56–62.
   PubMed Web of Science ®Google Scholar
• Zhang H, Gong W, Wang ZY, et al. (2014). Preparation, characterization, and pharmacodynamics of thermosensitive liposomes containing docetaxel. J Pharm Sci 103:2177–83.
   PubMed Web of Science ®Google Scholar
• Zhang JA, Anyarambhatla G, Ma L, et al. (2005). Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59:177–87.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Huan XE, Gao LL. (2009). A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors. Biomed Pharmacother 63:603–7.
   PubMed Web of Science ®Google Scholar
• Zhao L, Feng SS, Go ML. (2004). Investigation of molecular interactions between paclitaxel and DPPC by Langmuir film balance and differential scanning calorimetry. J Pharm Sci 93:86–98.
   PubMed Web of Science ®Google Scholar